Sarcoidosis: Challenging Diagnostic Aspects of an Old Disease
Overview
Authors
Affiliations
Over the past few years, there have been substantial advances in our understanding of sarcoidosis immunopathogenesis. Conversely, the etiology of the disease remains obscure for a number of reasons, including heterogeneity of clinical manifestations, often overlapping with other disorders, and insensitive and nonspecific diagnostic tests. While no cause has been definitely confirmed, there is increasing evidence that one or more infectious agents may cause the disease, although the organism may no longer be viable. Here we present 2 cases, in which sarcoidosis preceded tuberculosis and non-Hodgkin lymphoma. Development of new lesions in a patient with chronic/remitting sarcoidosis should be looked at with suspicion and promptly investigated in order to rule out an alternative/concomitant diagnosis. In such cases, tissue confirmation from the most accessible site, and bone marrow biopsy-if lymphoma is in the differential diagnosis-should be performed. In conclusion, we strongly advise that physicians be ready to reconsider the diagnosis of sarcoidosis in the presence of atypical manifestations or persistent/progressive disease despite conventional therapy.
Sarcoidosis: A Clinical Overview from Symptoms to Diagnosis.
Seve P, Pacheco Y, Durupt F, Jamilloux Y, Gerfaud-Valentin M, Isaac S Cells. 2021; 10(4).
PMID: 33807303 PMC: 8066110. DOI: 10.3390/cells10040766.
Sarcoidosis: Pitfalls and Challenging Mimickers.
Narula N, Iannuzzi M Front Med (Lausanne). 2021; 7:594275.
PMID: 33505980 PMC: 7829200. DOI: 10.3389/fmed.2020.594275.
Alogliptin-Induced Minimal Change Nephrotic Syndrome and Interstitial Nephritis.
Shima H, Okamoto T, Tashiro M, Inoue T, Masaki C, Tada H Kidney Med. 2020; 1(2):75-78.
PMID: 32734188 PMC: 7380391. DOI: 10.1016/j.xkme.2019.03.001.
Refractory Sarcoidosis: A Review.
El Jammal T, Jamilloux Y, Gerfaud-Valentin M, Valeyre D, Seve P Ther Clin Risk Manag. 2020; 16:323-345.
PMID: 32368072 PMC: 7173950. DOI: 10.2147/TCRM.S192922.
Boltezar L, Zagar I, Novakovic B Radiol Oncol. 2016; 50(4):355-359.
PMID: 27904442 PMC: 5120571. DOI: 10.1515/raon-2015-0033.